Haleon PLC (HLN) Balance Sheet
A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.
Total Assets Chart for Haleon PLC
Haleon PLC (HLN) total assets for FY2025 were GBP 32.6B, a -4.9% change from FY2024. Haleon PLC's total assets grew from GBP 35.7B in 2019 to GBP 32.6B in 2025 (-8.6% over 6 years). Total assets compound annual growth rate: 5-year CAGR of -0.9%.
Total Assets (British Pounds)
R&D as % of Revenue
Compare with
Key Stats
- Market Cap
- £32.13B
- Implied Share Price
- £3.65
- Enterprise Value
- £40.23B
- Revenue (TTM)
- £11.15B
- EBITDA
- £2.85B
- Profit Margin
- 14.55%
- Trailing P/E
- 20.29
- Forward P/E
- 18.02
- Price/Book (MRQ)
- 1.98
- Price/Sales (TTM)
- 2.88
- EV/EBITDA
- 14.21
- EV/Revenue
- 3.58
- Dividend Yield
- 1.96%
- Book Value
- £1.84
- Free Cash Flow (FY2025)
- £2.02B
- Free Cash Flow Yield
- 6.27%
Snapshot as of 27th August 2026 — not point-in-time controlled, may lag the live market by a few days.